1. Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease. Issue 2 (27th October 2020) Authors: Bansal, Rajat; Gordillo, Christian A; Abramova, Rachel; Assal, Amer; Mapara, Markus Y; Pereira, Marcus R; Reshef, Ran Journal: Transplant infectious disease Issue: Volume 23:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗